Both in Pharmaceuticals
Kura Oncology vs ArriVent BioPharma
Over the past year KURA returned +3.1% and AVBP returned −2.4%; their daily moves had a correlation of 0.26.
KURA +3.1% AVBP −2.4%Growth of $1, one year, split-adjusted
| Metric | KURA | AVBP |
|---|---|---|
| Price | $9.88 | $19.12 |
| Market cap | $878.9M | $942.8M |
| Today | −1.00% | +1.43% |
| 1 month | −15.8% | −36.9% |
| 6 months | +3.7% | −38.1% |
| Year to date | −4.9% | −5.0% |
| 1 year | −1.1% | −4.4% |
| Revenue growth (YoY) | +36.5% | — |
| Gross margin | 98.8% | — |
| Net margin | −327.3% | — |
| P/E (TTM) | — | — |
| Price / sales | 11.4× | — |
| Net cash | $509.2M | $373.1M |
| Dividend yield | — | — |
| Volatility (60d) | 54.7% | 138.8% |
| Short % of float | 18.5% | 25.2% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).